ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 Nasdaq:BSGM

Press/Media: Expert Comment

PeriodJul 8 2020

Media coverage

2

Media coverage

  • TitleViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 Nasdaq:BSGM
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date7/8/20
    PersonsCheng Huang, Slobodan Paessler
  • TitleViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 Nasdaq:BSGM
    Media name/outletFirstWord Pharma
    Country/TerritoryUnited States
    Date7/8/20
    URLwww.firstwordpharma.com/node/1738952
    PersonsCheng Huang, Slobodan Paessler

Keywords

  • COVID-19